Nursing care
Why serum potassium falls once insulin starts in DKA
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated October 2026
Short answer
In DKA the body is usually depleted of potassium even when the first serum result looks normal or high. Acidosis and lack of insulin hold potassium outside cells while osmotic diuresis and vomiting lose it from the body. Once insulin and fluids start, potassium moves back into cells and serum levels can fall quickly, unmasking the deficit.
Serum potassium is not the same as body potassium
Almost all of the body's potassium sits inside cells; the serum value measures only the small fraction outside them. A serum result therefore reflects both how much potassium the body holds and where it currently is. In DKA these two things move in opposite directions, which is why the admission value can mislead a nurse who reads it in isolation.
Total-body potassium falls because high glucose causes osmotic diuresis, carrying potassium out in large volumes of urine, and because vomiting adds further losses. At the same time, the serum level is propped up. Insulin normally helps move potassium into cells, so its absence leaves potassium outside, and the hyperosmolar, acidotic state also favours potassium leaving cells.
What insulin and fluids do to the serum level
Insulin stimulates the sodium-potassium pump on cell membranes, pulling potassium into cells. As treatment corrects the acidosis and dilutes the blood with intravenous fluid, the forces holding potassium outside are removed together. The serum value can fall quickly, and because the body was already depleted, there is little reserve to buffer that fall.
This is why guidance treats potassium as part of insulin safety. Merck describes withholding insulin until serum potassium reaches at least 3.3 mEq/L, and starting replacement when the initial level is below the upper end of normal, because a low-normal value on arrival signals marked depletion. Local DKA protocols set the exact thresholds and replacement plan, so confirm what your institution specifies.
Monitoring that follows the mechanism
Because the fall is expected, monitoring is front-loaded. Electrolytes are commonly checked every one to two hours early in treatment, and the nurse confirms that a potassium result is available before an insulin infusion begins. Urine output also matters: replacement plans usually assume the kidneys are producing urine, so low output is reported rather than ignored.
Watch the client as well as the laboratory value. Falling potassium can cause muscle weakness, cramps, reduced bowel activity and cardiac rhythm changes such as flattened T waves, ST depression and prominent U waves. Continuous cardiac monitoring is commonly used during treatment. Report a rapid downward trend, new weakness or arrhythmia promptly, because the next result may be lower still.
Why low urine output and magnesium change the picture
The kidneys are the main route for excreting potassium. In DKA, dehydration can reduce kidney perfusion, and replacement given into a client who is not passing urine can accumulate and cause dangerous hyperkalaemia instead. That is why many protocols link potassium replacement to confirmed urine output and current results, and why the nurse documents output carefully each hour during early treatment.
Magnesium often falls alongside potassium, and low magnesium makes the kidneys keep losing potassium, so hypokalaemia can be hard to correct until magnesium is addressed. A potassium level that stays low despite replacement is worth reporting with the magnesium result. Intravenous potassium is a high-alert medicine; give it only as prescribed, through the correct line and infusion pump, with the monitoring the protocol requires.
Worked scenario: the reassuring admission value
Imagine a hypothetical client with DKA whose first potassium is in the high-normal range. A colleague suggests that potassium can be ignored because the client is not hypokalaemic. The options are to start insulin and stop checking potassium, to avoid potassium replacement for the whole admission, or to follow the protocol for serial electrolytes and cardiac monitoring.
Following the protocol for repeated electrolytes and monitoring is correct. The admission value reflects a shift, not adequate stores, and insulin will move potassium back into cells. Two hours later the result has dropped and the client reports leg weakness; this is the predicted fall, and the nurse reports it promptly so the prescriber can adjust replacement under the protocol.
Sources and further reading
Merck Manual Professional: Diabetic ketoacidosis (DKA). Total-body potassium deficit with normal or high serum level, insulin driving potassium into cells, insulin threshold and monitoring frequency.
Merck Manual Professional: Hypokalemia. Insulin-induced transcellular shift, symptoms of low potassium and characteristic ECG changes.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our endocrine practice questions are the closest set to what this page covers.
Common questions
Why is potassium high on admission if the body is depleted?
Lack of insulin and the acidotic, hyperosmolar state keep potassium outside cells, raising the serum value even while urinary losses deplete total stores.
Why might insulin be delayed in a client with low potassium?
Insulin moves potassium into cells and can drive an already low serum level dangerously lower. Guidance describes correcting potassium to a protocol threshold before insulin starts; the prescriber and protocol decide timing.
What should the nurse watch for as potassium falls?
Muscle weakness, cramps, reduced bowel sounds and ECG changes such as flattened T waves or U waves. Report a falling trend promptly rather than waiting for symptoms.